Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

0.1740
-0.0277-13.73%
Volume:555.69K
Turnover:91.06K
Market Cap:4.43M
PE:-0.16
High:0.1740
Open:0.1640
Low:0.1500
Close:0.2017
52wk High:1.73
52wk Low:0.1500
Shares:25.48M
Float Shares:23.76M
Volume Ratio:247.29
T/O Rate:2.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0878
EPS(LYR):-1.5837
ROE:-241.14%
ROA:-118.81%
PB:1.47
PE(LYR):-0.11

Loading ...

BioRestorative Therapies announces 1-for-20 reverse stock split

TIPRANKS
·
15 hours ago

Biorestorative Therapies Announces Reverse Stock Split

Reuters
·
16 hours ago

BioRestorative Therapies Announces Reverse Stock Split

THOMSON REUTERS
·
16 hours ago

BioRestorative Therapies - Appoints Steven Brown as Chairman of the Board Effective September 1, 2026 - SEC Filing

THOMSON REUTERS
·
Yesterday

BioRestorative Therapies - Katharyn Field Steps Aside as Interim CEO and CFO Effective August 26, 2026 - SEC Filing

THOMSON REUTERS
·
Yesterday

BioRestorative Therapies Inc: Appoints Anna Skowron as Chief Financial Officer, Effective August 27, 2026

THOMSON REUTERS
·
Yesterday

BioRestorative Therapies Switches Auditor to Bush & Associates CPA, Dismisses CBIZ CPAs

Reuters
·
Yesterday

BioRestorative Therapies Gets NASDAQ Notice over Late Filing of Quarterly Report

Reuters
·
Aug 26

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 19

BioRestorative Therapies Delays Q2 10-Q Filing After CEO, CFO Resignations

Reuters
·
Aug 15

BioRestorative Therapies: Has not Made Decision to Discontinue Suspended Product Lines - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Conducting Review of the Documentation, Sourcing, Regulatory Status Associated with Suspended Products- SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Suspends All Orders, Shipments of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, on Aug 7 - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 07

BioRestorative Therapies Director Esha Randhawa Files Initial Beneficial Ownership Statement

Reuters
·
Jul 31

Biorestorative Therapies Files Form 3 Initial Beneficial Ownership Statement for Director Steven Collier Brown

Reuters
·
Jul 25

Biorestorative Therapies - Appoints Katharyn Field as CEO, President, and Interim CFO Effective July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17

Biorestorative Therapies - Lance Alstodt Resigns as President, CEO, Chairman and All Other Positions Effective July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17

Biorestorative Therapies - Robert Kristal Resigns as CFO and All Other Positions Effective July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 17

Biorestorative CEO Lance Alstodt, CFO Robert Kristal Resign Effective Immediately

Reuters
·
Jul 17